SLIT3 and melanoma: A different research group demonstrated that the in vitro ability of Slit3 to reduce the migratory activity of synovial cells from patients with rheumatoid arthritis and melanoma cells can be mimicked by small protein fragments derived from Slit3 containing only leucine rich repeat domain 2 [34, 50].